Novo Nordisk A/S (BKK:NOVOB80)

Novo Nordisk Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,163,262	13,209,364	15,867,615	10,523,708	8,506,891	4,867,326
Market Cap Growth	-39.11%	-16.75%	50.78%	23.71%	74.78%	19.76%
Enterprise Value	8,497,215	13,124,032	15,760,255	10,466,570	8,396,976	4,761,870
Last Close Price	1.83	2.96	-	-	-	-
PE Ratio	15.42	27.45	37.19	38.16	35.07	23.41
PS Ratio	5.07	9.55	13.40	11.97	11.90	7.77
PB Ratio	9.42	19.32	29.21	25.38	23.68	15.58
P/TBV Ratio	25.28	85.58	67.43	65.10	60.74	23.12
P/FCF Ratio	24.25	37.56	37.45	31.75	34.42	21.39
P/OCF Ratio	12.93	22.92	28.58	26.86	30.45	18.99
EV/Sales Ratio	5.53	9.49	13.31	11.91	11.74	7.60
EV/EBITDA Ratio	10.46	18.78	27.97	25.98	25.93	16.48
EV/EBIT Ratio	11.37	19.69	29.53	27.87	27.92	17.83
EV/FCF Ratio	25.25	37.32	37.20	31.57	33.97	20.93
Debt / Equity Ratio	0.60	0.72	0.25	0.31	0.38	0.16
Debt / EBITDA Ratio	0.61	0.69	0.24	0.31	0.41	0.17
Debt / FCF Ratio	1.53	1.39	0.33	0.39	0.55	0.23
Asset Turnover	0.69	0.74	0.84	0.81	0.83	0.94
Inventory Turnover	1.22	1.20	1.26	1.29	1.24	1.16
Quick Ratio	0.53	0.52	0.62	0.67	0.65	0.64
Current Ratio	0.78	0.74	0.82	0.90	0.86	0.94
Return on Equity (ROE)	71.47%	80.77%	88.07%	72.00%	71.24%	69.70%
Return on Assets (ROA)	21.11%	22.41%	23.55%	21.69%	21.81%	25.01%
Return on Invested Capital (ROIC)	42.81%	46.03%	53.89%	45.74%	43.27%	49.84%
Return on Capital Employed (ROCE)	55.30%	56.30%	72.30%	62.80%	62.30%	72.50%
Earnings Yield	6.49%	3.64%	2.69%	2.62%	2.85%	4.27%
FCF Yield	4.12%	2.66%	2.67%	3.15%	2.90%	4.67%
Dividend Yield	2.23%	1834.07%	-	-	-	-
Payout Ratio	49.88%	43.71%	37.96%	45.57%	45.05%	47.75%
Buyback Yield / Dilution	0.46%	0.71%	1.10%	1.34%	1.58%	1.63%
Total Shareholder Return	2.69%	1834.78%	1.10%	1.34%	1.58%	1.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.